Roundtable Discussion: Advancing Disease Prediction through the Development & Validation of Prognostic Biomarkers for Personalized IBD Treatments
Time: 11:30 am
day: Day One
Details:
- What is the clinical utility of biomarkers in predicting disease course?
- Can biopharma identify immune profiles linked to patient outcomes in early IBD stages?
- How can we accelerate the validation of biomarkers to enhance treatment efficacy?
